Ftse Mib
34.114,92
-0,76%
DAX
18.498,15
-0,55%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.665,63
-3,37%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AbCellera Biologics Inc (ABCL) AbCellera Biologics Inc (ABCL) Notizie

ABCL

AbCellera Biologics (ABCL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL
DataOraFonteTitoloSimboloCompagnia
20/09/202315:00Business WireAbCellera Expands Multi-Target Antibody Discovery Collaboration with RegeneronNASDAQ:ABCLAbCellera Biologics Inc
14/09/202322:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
13/09/202315:00Business WireAbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in OncologyNASDAQ:ABCLAbCellera Biologics Inc
03/08/202322:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
03/08/202322:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
03/08/202322:05Business WireAbCellera Reports Q2 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
24/07/202322:05Business WireAbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for RehearingNASDAQ:ABCLAbCellera Biologics Inc
06/07/202322:05Business WireAbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023NASDAQ:ABCLAbCellera Biologics Inc
30/05/202319:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABCLAbCellera Biologics Inc
29/05/202322:05Business WireAbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023NASDAQ:ABCLAbCellera Biologics Inc
24/05/202319:10Business WireAbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to PatientsNASDAQ:ABCLAbCellera Biologics Inc
04/05/202323:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABCLAbCellera Biologics Inc
04/05/202322:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABCLAbCellera Biologics Inc
04/05/202322:05Business WireAbCellera Reports Q1 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
28/04/202323:02Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ABCLAbCellera Biologics Inc
17/04/202315:10Business WireAbCellera Presents New Data on T-Cell Engager Platform at AACR 2023NASDAQ:ABCLAbCellera Biologics Inc
11/04/202322:05Business WireAbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023NASDAQ:ABCLAbCellera Biologics Inc
06/04/202322:05Business WireAbCellera to Report First Quarter 2023 Financial Results on May 4, 2023NASDAQ:ABCLAbCellera Biologics Inc
22/03/202314:00Business WireAbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious DiseaseNASDAQ:ABCLAbCellera Biologics Inc
14/03/202321:30Business WireAbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023NASDAQ:ABCLAbCellera Biologics Inc
23/02/202322:05Business WireAbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023NASDAQ:ABCLAbCellera Biologics Inc
21/02/202322:05Business WireAbCellera Reports Full Year 2022 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
13/02/202320:50Edgar (US Regulatory)Schedule 13g
(sc 13g/a)		NASDAQ:ABCLAbCellera Biologics Inc
06/02/202322:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ABCLAbCellera Biologics Inc
01/02/202322:05Business WireAbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023NASDAQ:ABCLAbCellera Biologics Inc
24/01/202322:05Business WireAbCellera to Report Full Year 2022 Financial Results on February 21, 2023NASDAQ:ABCLAbCellera Biologics Inc
20/01/202301:00Business WireAbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture PatentNASDAQ:ABCLAbCellera Biologics Inc
04/01/202322:05Business WireAbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023NASDAQ:ABCLAbCellera Biologics Inc
15/12/202213:00Business WireAbCellera and AbbVie Partner to Advance New Antibody TherapiesNASDAQ:ABCLAbCellera Biologics Inc
01/12/202220:35TipRanksAbCellera Biologics (ABCL) Gets a Buy from Berenberg BankNASDAQ:ABCLAbCellera Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL

La tua Cronologia

NASDAQ
PRTC
PureTech Health
NASDAQ
GLUU
Glu Mobile
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network